On Mar 15, 2022 Causeway Sensors closed a Venture - Series Unknown round and raised…
- New research reveals that nearly one-third of all women in developing countries become mothers during adolescenceon July 5, 2022 at 7:21 pm
Nearly a third of all women in developing countries begin childbearing at age 19 and younger, and nearly half of first births to adolescents are to children or girls aged 17 and younger, reveals research released today by UNFPA, the UN sexual and reproductive health agency.
- Men at heightened risk of prostate cancer may benefit from healthy lifestyle changeson July 5, 2022 at 7:15 pm
A new study confirms that for men who are at heightened genetic risk of developing prostate cancer, genes are not destiny. Investigators from Brigham and Women’s Hospital looked at outcomes for men with nearly 30 years of follow-up for prostate cancer risk and prostate cancer mortality who were enrolled in two cohort studies—the Health Professionals Follow-up Study and the Physicians’ Health Study. The team found that while men who followed a healthy or unhealthy lifestyle were equally likely to be diagnosed with prostate cancer, adherence to a healthy lifestyle was associated with close to a 50 percent reduced risk of developing lethal prostate cancer. Results are published in European Urology.
- For COVID-19, endemic stage could be two years awayon July 5, 2022 at 6:40 pm
Illnesses like the common cold and the flu have become endemic in human populations; everyone gets them every now and then, but for most people, they aren’t especially harmful. COVID-19 will eventually transition to endemic status at some point—but when?
- How daily testing saved a city’s emergency services from a COVID catastropheon July 5, 2022 at 6:28 pm
University of Liverpool researchers have played their part in an evaluation showing that key workers in Liverpool carrying out daily testing prevented COVID-19 from crippling emergency services.
- Some pre-existing mutant strains of virus causing COVID may resist Paxlovidon July 5, 2022 at 6:25 pm
An analysis of SARS-CoV-2 variants sequenced in a scientific database GISAID has found some mutant strains of the virus could resist the COVID-19 medication Paxlovid.